Open AccessTrend of clinical drug trials in type 2 diabetes mellitus over last decade
Author(s) -
Rakesh Parikh,
Kirti Pandia,
Mahesh Goyal,
Meenakshi Sharma,
M S Dolima
Publication year - 2011
Publication title -
perspectives in clinical research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.649
H-Index - 8
eISSN - 2229-5488
pISSN - 2229-3485
DOI - 10.4103/2229-3485.80369
Subject(s) - medicine , clinical trial , drug , population , type 2 diabetes mellitus , type 2 diabetes , diabetes mellitus , china , drug trial , pharmacology , environmental health , endocrinology , geography , archaeology
Type 2 diabetes mellitus (Type 2 DM) has been recognized as the recent pandemic; India and China competing each other for the title-"Diabetes Capital of the World." A number of new drugs have been recently available and has lead to a boom in the clinical drug trial industry. We intend to evaluate the trend of clinical drug trials in Type 2 DM over last one decade.